Mark Engel
Fondateur chez Excel PharmaStudies, Inc.
Profil
Mark Engel is the founder of Excel PharmaStudies, Inc. He is currently the Chief Executive Officer & Director at Phagelux, Inc., the Chairman & Chief Executive Officer at Precisio Biotix Therapeutics, Inc., and the Chairman at Phagelux (Canada), Inc.
Postes actifs de Mark Engel
| Sociétés | Poste | Début |
|---|---|---|
Excel PharmaStudies, Inc.
 Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China. | Fondateur | - |
Phagelux, Inc.
 Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Directeur Général | - |
Phagelux (Canada), Inc.
 Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Président | 11/03/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Excel PharmaStudies, Inc.
Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China. | Commercial Services |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Health Technology |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Health Technology |